DOVA

Dova Pharmaceuticals Inc.CIK 1685071 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for DOVA PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for DOVA

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Hoitt Jason	Chief Commercial Officer	10	$0	$236.4K	2019-11-12
Stalfort Sean	Director	2	$194.1K	$0	2019-11-12
Laliberte Kevin	Sr. VP, Product Development	16	$105.4K	$204.5K	2019-11-12
ZACCARDELLI DAVID	President & CEO	8	$60.7K	$313.8K	2019-11-12
Goldman Steven M.	Director	30	$2.39M	$0	2019-11-12
Manning Paul B	Director, 10% Owner	21	$10.47M	$0	2019-11-12
Hahn Mark W	Chief Financial Officer	10	$15.7K	$43.6K	2019-11-12
ALLEN LEE F MD PhD	Chief Medical Officer	8	$59.5K	$55.2K	2019-11-12
Novak Alfred J	Director	6	$0	$0	2019-11-12
Wysenski Nancy	Director	5	$0	$0	2019-11-12
JEFFS ROGER	Director	10	$720.4K	$18.5K	2019-11-12
EDELMAN JOSEPH	10% Owner	4	$1.42M	$0	2019-11-12
PERCEPTIVE ADVISORS LLC	10% Owner	13	$11.11M	$0	2019-07-05
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD	10% Owner	8	$4.13M	$0	2019-07-03
Sapir Alex	President & CEO	4	$837.1K	$0	2018-08-14
PBM Capital Investments, LLC	10% Owner	2	$0	$0	2017-11-09

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
ALLEN LEE F MD PhD	Chief Medical Officer	D To issuer deriv	2019-11-12	2019-11-12	10,000	—	$0	0	SEC↗
ALLEN LEE F MD PhD	Chief Medical Officer	D To issuer deriv	2019-11-12	2019-11-12	251,466	—	$0	0	SEC↗
Goldman Steven M.	Director	D To issuer deriv	2019-11-12	2019-11-12	10,083	—	$0	0	SEC↗
Goldman Steven M.	Director	D To issuer deriv	2019-11-12	2019-11-12	8,333	—	$0	0	SEC↗
Hahn Mark W	Chief Financial Officer	D To issuer deriv	2019-11-12	2019-11-12	250,000	—	$0	0	SEC↗
Hahn Mark W	Chief Financial Officer	D To issuer deriv	2019-11-12	2019-11-12	50,000	—	$0	0	SEC↗
Hoitt Jason	Chief Commercial Officer	D To issuer deriv	2019-11-12	2019-11-12	250,000	—	$0	0	SEC↗
JEFFS ROGER	Director	D To issuer deriv	2019-11-12	2019-11-12	10,000	—	$0	0	SEC↗
JEFFS ROGER	Director	D To issuer deriv	2019-11-12	2019-11-12	33,000	—	$0	0	SEC↗
Laliberte Kevin	Sr. VP, Product Development	D To issuer deriv	2019-11-12	2019-11-12	115,500	—	$0	0	SEC↗
Laliberte Kevin	Sr. VP, Product Development	D To issuer deriv	2019-11-12	2019-11-12	50,000	—	$0	0	SEC↗
Laliberte Kevin	Sr. VP, Product Development	D To issuer deriv	2019-11-12	2019-11-12	10,000	—	$0	0	SEC↗
Laliberte Kevin	Sr. VP, Product Development	D To issuer deriv	2019-11-12	2019-11-12	24,750	—	$0	0	SEC↗
Novak Alfred J	Director	D To issuer deriv	2019-11-12	2019-11-12	33,000	—	$0	0	SEC↗
Novak Alfred J	Director	D To issuer deriv	2019-11-12	2019-11-12	10,000	—	$0	0	SEC↗
Wysenski Nancy	Director	D To issuer deriv	2019-11-12	2019-11-12	10,000	—	$0	0	SEC↗
ZACCARDELLI DAVID	President & CEO	D To issuer deriv	2019-11-12	2019-11-12	1,000,000	—	$0	0	SEC↗
ALLEN LEE F MD PhD	Chief Medical Officer	D To issuer	2019-11-12	2019-11-12	9,635	—	$0	0	SEC↗
Goldman Steven M.	Director	D To issuer	2019-11-12	2019-11-12	144,280	—	$0	0	SEC↗
Goldman Steven M.	Director	D To issuer	2019-11-12	2019-11-12	5,000	—	$0	0	SEC↗
Hahn Mark W	Chief Financial Officer	D To issuer	2019-11-12	2019-11-12	9,024	—	$0	0	SEC↗
Hoitt Jason	Chief Commercial Officer	D To issuer	2019-11-12	2019-11-12	9,970	—	$0	0	SEC↗
JEFFS ROGER	Director	D To issuer	2019-11-12	2019-11-12	66,993	—	$0	0	SEC↗
Laliberte Kevin	Sr. VP, Product Development	D To issuer	2019-11-12	2019-11-12	4,761	—	$0	0	SEC↗
Manning Paul B	Director, 10% Owner	U Tender	2019-11-12	2019-11-12	12,979,016	$27.50	$356.92M	0	SEC↗
Manning Paul B	Director, 10% Owner	U Tender	2019-11-12	2019-11-12	1,783,226	$27.50	$49.04M	0	SEC↗
Novak Alfred J	Director	D To issuer	2019-11-12	2019-11-12	6,901	—	$0	0	SEC↗
Stalfort Sean	Director	U Tender	2019-11-12	2019-11-12	635,665	$27.50	$17.48M	0	SEC↗
Wysenski Nancy	Director	D To issuer	2019-11-12	2019-11-12	6,274	—	$0	0	SEC↗
ZACCARDELLI DAVID	President & CEO	D To issuer	2019-11-12	2019-11-12	76,647	—	$0	0	SEC↗
EDELMAN JOSEPH	10% Owner	J Other	2019-11-12	2019-11-15	3,125,851	—	$0	0	SEC↗
ZACCARDELLI DAVID	President & CEO	S Sale	2019-10-01	2019-10-02	5,275	$27.90	$147.2K	76,647	SEC↗
Laliberte Kevin	Sr. VP, Product Development	S Sale	2019-09-30	2019-10-02	3,100	$28.00	$86.8K	5,357	SEC↗
Laliberte Kevin	Sr. VP, Product Development	S Sale	2019-09-30	2019-10-02	596	$28.00	$16.7K	4,761	SEC↗
Hoitt Jason	Chief Commercial Officer	S Sale	2019-09-30	2019-10-02	2,387	$28.00	$66.8K	9,970	SEC↗
Hahn Mark W	Chief Financial Officer	S Sale	2019-09-30	2019-10-02	775	$28.00	$21.7K	9,024	SEC↗
ALLEN LEE F MD PhD	Chief Medical Officer	S Sale	2019-09-30	2019-10-02	978	$28.00	$27.4K	9,635	SEC↗
Laliberte Kevin	Sr. VP, Product Development	S Sale	2019-09-25	2019-09-27	3,100	$20.00	$62.0K	8,457	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2019-08-09	2019-08-12	28,062	$15.87	$445.3K	12,979,016	SEC↗
Laliberte Kevin	Sr. VP, Product Development	S Sale	2019-07-31	2019-08-01	1,389	$15.97	$22.2K	11,557	SEC↗
ALLEN LEE F MD PhD	Chief Medical Officer	A Award deriv	2019-07-30	2019-08-01	10,000	—	$0	10,000	SEC↗
Laliberte Kevin	Sr. VP, Product Development	A Award deriv	2019-07-30	2019-08-01	10,000	—	$0	10,000	SEC↗
Hoitt Jason	Chief Commercial Officer	S Sale	2019-07-15	2019-07-16	900	$16.44	$14.8K	12,357	SEC↗
Hoitt Jason	Chief Commercial Officer	S Sale	2019-07-15	2019-07-16	6,680	$15.10	$100.9K	13,257	SEC↗
EDELMAN JOSEPH	10% Owner	P Buy	2019-07-11	2019-07-11	42,916	$16.67	$715.4K	3,708,705	SEC↗
EDELMAN JOSEPH	10% Owner	P Buy	2019-07-10	2019-07-11	12,354	$16.89	$208.7K	3,665,789	SEC↗
EDELMAN JOSEPH	10% Owner	P Buy	2019-07-09	2019-07-11	29,834	$16.61	$495.5K	3,653,435	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2019-07-05	2019-07-09	50,000	$16.46	$823.0K	3,632,601	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	10% Owner	P Buy	2019-07-03	2019-07-03	1,705	$16.67	$28.4K	3,573,601	SEC↗
ZACCARDELLI DAVID	President & CEO	S Sale	2019-07-02	2019-07-03	4,551	$16.22	$73.8K	81,922	SEC↗
ZACCARDELLI DAVID	President & CEO	S Sale	2019-07-02	2019-07-03	5,899	$15.73	$92.8K	86,473	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	10% Owner	P Buy	2019-07-02	2019-07-03	715	$16.14	$11.5K	3,571,896	SEC↗
ALLEN LEE F MD PhD	Chief Medical Officer	S Sale	2019-07-01	2019-07-02	1,957	$14.19	$27.8K	10,613	SEC↗
Laliberte Kevin	Sr. VP, Product Development	S Sale	2019-07-01	2019-07-02	1,191	$14.17	$16.9K	12,946	SEC↗
JEFFS ROGER	Director	S Sale	2019-07-01	2019-07-02	1,308	$14.17	$18.5K	66,993	SEC↗
Hahn Mark W	Chief Financial Officer	S Sale	2019-07-01	2019-07-02	1,545	$14.17	$21.9K	9,799	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	10% Owner	P Buy	2019-07-01	2019-07-03	18,121	$14.24	$258.0K	3,571,181	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2019-06-28	2019-07-01	39,383	$14.48	$570.3K	3,553,060	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2019-06-28	2019-07-01	60,617	$13.97	$846.8K	3,513,560	SEC↗
Hoitt Jason	Chief Commercial Officer	S Sale	2019-06-28	2019-07-02	150	$14.40	$2.2K	19,937	SEC↗
Hoitt Jason	Chief Commercial Officer	S Sale	2019-06-28	2019-07-02	2,237	$13.77	$30.8K	20,087	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2019-06-27	2019-07-01	186,696	$13.58	$2.54M	3,453,060	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2019-06-27	2019-07-01	140,513	$12.46	$1.75M	3,266,364	SEC↗
Goldman Steven M.	Director	M Exercise deriv	2019-06-26	2019-06-27	834	—	$0	8,233	SEC↗
Goldman Steven M.	Director	M Exercise deriv	2019-06-26	2019-06-27	916	—	$0	10,084	SEC↗
Goldman Steven M.	Director	M Exercise	2019-06-26	2019-06-27	916	$7.32	$6.7K	143,446	SEC↗
Goldman Steven M.	Director	M Exercise	2019-06-26	2019-06-27	834	$9.36	$7.8K	144,280	SEC↗
Goldman Steven M.	Director	M Exercise deriv	2019-06-20	2019-06-24	833	—	$0	9,167	SEC↗
Goldman Steven M.	Director	M Exercise deriv	2019-06-20	2019-06-24	917	—	$0	11,000	SEC↗
Goldman Steven M.	Director	M Exercise	2019-06-20	2019-06-24	917	$7.32	$6.7K	141,697	SEC↗
Goldman Steven M.	Director	M Exercise	2019-06-20	2019-06-24	833	$9.36	$7.8K	142,530	SEC↗
Goldman Steven M.	Director	M Exercise deriv	2019-05-13	2019-06-03	3,668	—	$0	11,917	SEC↗
Goldman Steven M.	Director	M Exercise	2019-05-13	2019-06-03	3,668	$7.32	$26.8K	140,780	SEC↗
Wysenski Nancy	Director	A Award deriv	2019-04-26	2019-04-30	10,000	—	$0	10,000	SEC↗
Novak Alfred J	Director	A Award deriv	2019-04-26	2019-04-30	10,000	—	$0	10,000	SEC↗
JEFFS ROGER	Director	A Award deriv	2019-04-26	2019-04-30	10,000	—	$0	10,000	SEC↗
Goldman Steven M.	Director	A Award deriv	2019-04-26	2019-04-30	10,000	—	$0	10,000	SEC↗
Hoitt Jason	Chief Commercial Officer	S Sale	2019-04-08	2019-04-10	2,387	$8.77	$20.9K	22,324	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2019-03-07	2019-03-08	68,000	$7.48	$508.6K	12,950,954	SEC↗
Wysenski Nancy	Director	A Award	2019-02-05	2019-02-07	6,274	—	$0	6,274	SEC↗
Novak Alfred J	Director	A Award	2019-02-05	2019-02-07	6,901	—	$0	6,901	SEC↗
JEFFS ROGER	Director	A Award	2019-02-05	2019-02-07	6,901	—	$0	68,301	SEC↗
Goldman Steven M.	Director	A Award	2019-02-05	2019-02-07	7,528	—	$0	132,529	SEC↗
Hahn Mark W	Chief Financial Officer	A Award deriv	2019-01-04	2019-01-08	250,000	—	$0	250,000	SEC↗
Laliberte Kevin	Sr. VP, Product Development	A Award deriv	2019-01-04	2019-01-08	50,000	—	$0	50,000	SEC↗
ALLEN LEE F MD PhD	Chief Medical Officer	A Award	2019-01-04	2019-01-08	9,070	—	$0	12,570	SEC↗
Hahn Mark W	Chief Financial Officer	A Award	2019-01-04	2019-01-08	8,844	—	$0	11,344	SEC↗
Laliberte Kevin	Sr. VP, Product Development	A Award	2019-01-04	2019-01-08	7,937	—	$0	14,137	SEC↗
Goldman Steven M.	Director	M Exercise deriv	2019-01-02	2019-06-03	4,583	—	$0	15,585	SEC↗
Goldman Steven M.	Director	M Exercise	2019-01-02	2019-06-03	4,583	$7.32	$33.5K	137,112	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2018-12-21	2018-12-21	121,666	$6.44	$783.5K	12,876,120	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2018-12-21	2018-12-21	6,834	$7.10	$48.5K	12,882,954	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2018-12-20	2018-12-20	266,631	$6.17	$1.65M	12,754,454	SEC↗
Stalfort Sean	Director	P Buy	2018-12-20	2018-12-21	31,000	$6.26	$194.1K	635,665	SEC↗
ZACCARDELLI DAVID	President & CEO	P Buy	2018-12-20	2018-12-21	10,000	$6.07	$60.7K	92,372	SEC↗
JEFFS ROGER	Director	P Buy	2018-12-20	2018-12-21	1,169	$6.25	$7.3K	61,400	SEC↗
Hoitt Jason	Chief Commercial Officer	A Award deriv	2018-12-19	2018-12-20	250,000	—	$0	250,000	SEC↗
ZACCARDELLI DAVID	President & CEO	A Award deriv	2018-12-19	2018-12-21	1,000,000	—	$0	1,000,000	SEC↗
Hoitt Jason	Chief Commercial Officer	A Award	2018-12-19	2018-12-20	24,711	—	$0	24,711	SEC↗
Hahn Mark W	Chief Financial Officer	P Buy	2018-12-19	2018-12-21	2,500	$6.28	$15.7K	2,500	SEC↗
ZACCARDELLI DAVID	President & CEO	A Award	2018-12-19	2018-12-21	82,372	—	$0	82,372	SEC↗
JEFFS ROGER	Director	P Buy	2018-12-19	2018-12-21	28,831	$6.22	$179.3K	60,231	SEC↗
Hahn Mark W	Chief Financial Officer	A Award deriv	2018-10-08	2018-10-10	50,000	—	$0	50,000	SEC↗
Sapir Alex	President & CEO	P Buy	2018-08-14	2018-08-15	21,700	$22.83	$495.4K	21,700	SEC↗
Goldman Steven M.	Director	M Exercise deriv	2018-08-13	2018-08-15	1,832	—	$0	20,168	SEC↗
Goldman Steven M.	Director	M Exercise	2018-08-13	2018-08-15	1,832	$7.32	$13.4K	125,001	SEC↗
Wysenski Nancy	Director	A Award deriv	2018-06-25	2018-06-26	30,000	—	$0	30,000	SEC↗
Goldman Steven M.	Director	P Buy	2018-06-21	2018-06-25	5,000	$30.22	$151.1K	123,169	SEC↗
Goldman Steven M.	Director	A Award deriv	2018-06-19	2018-06-21	10,000	—	$0	10,000	SEC↗
JEFFS ROGER	Director	A Award deriv	2018-06-19	2018-06-21	10,000	—	$0	10,000	SEC↗
Novak Alfred J	Director	A Award deriv	2018-06-19	2018-06-21	10,000	—	$0	10,000	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2018-06-11	2018-06-13	5,591	$29.82	$166.7K	3,125,851	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2018-06-11	2018-06-13	14,109	$29.18	$411.7K	3,120,260	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	10% Owner	P Buy	2018-06-08	2018-06-12	2,000	$28.97	$57.9K	3,106,151	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	10% Owner	P Buy	2018-06-08	2018-06-12	23,000	$28.62	$658.3K	3,104,151	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2018-06-07	2018-06-08	3,400	$28.03	$95.3K	12,487,823	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2018-06-07	2018-06-08	6,600	$27.52	$181.6K	12,484,423	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2018-06-07	2018-06-11	22,377	$27.63	$618.3K	3,053,528	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2018-06-07	2018-06-11	8,400	$29.16	$244.9K	3,081,151	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2018-06-07	2018-06-11	19,223	$28.40	$545.9K	3,072,751	SEC↗
Goldman Steven M.	Director	M Exercise deriv	2018-06-06	2018-06-07	11,000	—	$0	22,000	SEC↗
Goldman Steven M.	Director	M Exercise	2018-06-06	2018-06-07	11,000	$7.32	$80.5K	118,169	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2018-06-06	2018-06-08	17,000	$28.85	$490.4K	12,477,823	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	10% Owner	P Buy	2018-06-06	2018-06-08	51,763	$28.99	$1.50M	3,031,151	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	10% Owner	P Buy	2018-06-06	2018-06-08	48,237	$28.30	$1.37M	2,979,388	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2018-06-05	2018-06-06	46,980	$26.04	$1.22M	12,407,803	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2018-06-05	2018-06-06	53,020	$26.93	$1.43M	12,460,823	SEC↗
Goldman Steven M.	Director	P Buy	2018-06-05	2018-06-06	15,000	$26.41	$396.1K	107,169	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2018-06-05	2018-06-07	40,670	$25.45	$1.04M	2,871,821	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2018-06-05	2018-06-07	3,168	$27.13	$85.9K	2,931,151	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2018-06-05	2018-06-07	56,162	$26.31	$1.48M	2,927,983	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2018-06-04	2018-06-06	11,800	$24.75	$292.1K	12,360,823	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2018-06-04	2018-06-06	8,200	$24.02	$197.0K	12,349,023	SEC↗
PERCEPTIVE LIFE SCIENCES MASTE	10% Owner	P Buy	2018-06-04	2018-06-06	10,000	$25.07	$250.7K	2,831,151	SEC↗
Laliberte Kevin	Sr. VP, Product Development	A Award deriv	2018-03-12	2018-03-14	50,000	—	$0	50,000	SEC↗
Hahn Mark W	Chief Financial Officer	A Award deriv	2018-01-31	2018-02-01	175,000	—	$0	175,000	SEC↗
Sapir Alex	President & CEO	M Exercise deriv	2017-12-22	2017-12-27	26,809	—	$0	887,291	SEC↗
Sapir Alex	President & CEO	M Exercise	2017-12-22	2017-12-27	26,809	$3.73	$100.0K	46,909	SEC↗
PBM Capital Investments, LLC	10% Owner	J Other	2017-11-09	2017-11-13	12,214,953	—	$0	12,340,823	SEC↗
PBM Capital Investments, LLC	10% Owner	J Other	2017-11-09	2017-11-13	12,214,953	—	$0	0	SEC↗
Laliberte Kevin	Sr. VP, Product Development	A Award deriv	2017-11-06	2017-11-08	24,750	—	$0	24,750	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2017-08-16	2017-08-17	1,379	$25.62	$35.3K	125,770	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2017-08-16	2017-08-17	100	$26.81	$2.7K	125,870	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2017-08-16	2017-08-17	3,521	$24.87	$87.6K	124,391	SEC↗
Goldman Steven M.	Director	P Buy	2017-08-15	2017-08-17	11,011	$22.54	$248.2K	92,169	SEC↗
Goldman Steven M.	Director	P Buy	2017-08-15	2017-08-17	9,158	$21.86	$200.2K	81,158	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2017-08-15	2017-08-17	7,870	$22.39	$176.2K	120,870	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2017-08-15	2017-08-17	13,000	$21.16	$275.1K	113,000	SEC↗
Sapir Alex	President & CEO	P Buy	2017-07-05	2017-07-07	20,100	$17.00	$341.7K	20,100	SEC↗
Goldman Steven M.	Director	P Buy	2017-07-05	2017-07-07	30,000	$19.25	$577.5K	72,000	SEC↗
Goldman Steven M.	Director	P Buy	2017-07-05	2017-07-07	42,000	$17.00	$714.0K	42,000	SEC↗
JEFFS ROGER	Director	P Buy	2017-07-05	2017-07-07	31,400	$17.00	$533.8K	31,400	SEC↗
Laliberte Kevin	Sr. VP, Product Development	P Buy	2017-07-05	2017-07-07	6,200	$17.00	$105.4K	6,200	SEC↗
ALLEN LEE F MD PhD	Chief Medical Officer	P Buy	2017-07-05	2017-07-07	3,500	$17.00	$59.5K	3,500	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2017-07-05	2017-07-07	100,000	$17.00	$1.70M	100,000	SEC↗
Manning Paul B	Director, 10% Owner	P Buy	2017-07-05	2017-07-07	50,000	$17.00	$850.0K	1,783,226	SEC↗
Goldman Steven M.	Director	P Buy	2017-07-05	2017-08-17	5,000	$19.64	$98.2K	5,000	SEC↗